Vimarsana
Biggest News Aggregation in the World

Page 3 - Therapeutic Experience Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutic Experience Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutic Experience Program Today - Breaking & Trending Today

Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program - Vimarsana News

Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program

-- Second Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS® therapy for gait... | May 17, 2022

Helius Medical Technologies' (HSDT) CEO Dane Andreeff on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Helius Medical Technologies' (HSDT) CEO Dane Andreeff on Q1 2022 Results - Earnings Call Transcript

Helius Medical Technologies, Inc. (NASDAQ:NASDAQ:HSDT) Q1 2022 Earnings Conference Call May 12, 2022 9:00 AM ET Company Participants Judy DiClemente – In-Site Communications, Inc.

Helius Medical Technologies, Inc. Reports Fourth Quarter - Vimarsana News

Helius Medical Technologies, Inc. Reports Fourth Quarter

NEWTOWN, Pa., March 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused...

Helius Medical Technologies, Inc. Reports Inducement Grants - Vimarsana News

Helius Medical Technologies, Inc. Reports Inducement Grants

NEWTOWN, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused...

Helius Medical Technologies, Inc. Provides Corporate - Vimarsana News

Helius Medical Technologies, Inc. Provides Corporate

-- Fourth Quarter 2021 Revenue Projected to Range from $250,000 to $260,000 -- -- Unaudited Year End Cash Balance of $11 million -- -- Continued...